Hem › Lipoid nefros › Texas
Kliniska studier för Lipoid nefros i Texas
4 studier för Lipoid nefros söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
RekryterarFas 2
Ålder 16 till 75 · Alla kön · Uppdaterad 23 sep. 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
- Clinical Advancement Center, San Antonio
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
RekryterarObservationsstudie
Upp till ålder 80 · Alla kön · Uppdaterad 10 juni 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
RekryterarFas 2
Ålder 1 till 17 · Alla kön · Uppdaterad 12 maj 2026 · NCT05003986Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.